Filed: 11/14/2024ACC: 0001855655-24-000014
📋 What this filing means
PARADIGM BIOCAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $2.96B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$2.96B
Total AUM (reported)
83.25M
Total Shares
Allocation by class
COM$2.05B69.4%
COMMON STOCK$400.85M13.6%
SPONSORED ADR$305.38M10.3%
COM NEW$49.56M1.7%
CL A$48.48M1.6%
CLASS A ORD$46.97M1.6%
SHS$44.55M1.5%
Portfolio Concentration
Top 3$1.17B39.7%
4–10$869.56M29.4%
11–25$781.98M26.5%
Rest$131.64M4.5%
Top 3 weight
39.7%
Top 10 weight
69.1%
Voting Authority Distribution
Total shares with voting rights: 83.25M
Sole
Full voting authority
83.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
NUVALENT INC
SOLEShares5M
TypeSH
Market value$511.50M
17.30%
Sole
5M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares4.80M
TypeSH
Market value$400.85M
13.56%
Sole
4.80M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares480.37K
TypeSH
Market value$260.40M
8.81%
Sole
480.37K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares5.31M
TypeSH
Market value$240.99M
8.15%
Sole
5.31M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares2.52M
TypeSH
Market value$128.60M
4.35%
Sole
2.52M
Shared
0.00
None
0.00
MERUS N V
SOLEShares2.45M
TypeSH
Market value$122.65M
4.15%
Sole
2.45M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares2.40M
TypeSH
Market value$109.06M
3.69%
Sole
2.40M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares904.53K
TypeSH
Market value$103.36M
3.50%
Sole
904.53K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares4.33M
TypeSH
Market value$84.63M
2.86%
Sole
4.33M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares2.44M
TypeSH
Market value$80.27M
2.72%
Sole
2.44M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares2.79M
TypeSH
Market value$74.44M
2.52%
Sole
2.79M
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares1.50M
TypeSH
Market value$73.60M
2.49%
Sole
1.50M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares2.90M
TypeSH
Market value$65.88M
2.23%
Sole
2.90M
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares5.50M
TypeSH
Market value$65.71M
2.22%
Sole
5.50M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares2.34M
TypeSH
Market value$57.63M
1.95%
Sole
2.34M
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares4.09M
TypeSH
Market value$53.74M
1.82%
Sole
4.09M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.61M
TypeSH
Market value$49.79M
1.68%
Sole
4.61M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares1.10M
TypeSH
Market value$48.48M
1.64%
Sole
1.10M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares931.48K
TypeSH
Market value$46.97M
1.59%
Sole
931.48K
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares200.34K
TypeSH
Market value$44.98M
1.52%
Sole
200.34K
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares3.90M
TypeSH
Market value$44.55M
1.51%
Sole
3.90M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares701.82K
TypeSH
Market value$41.22M
1.39%
Sole
701.82K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares1.36M
TypeSH
Market value$38.85M
1.31%
Sole
1.36M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares2.32M
TypeSH
Market value$38.85M
1.31%
Sole
2.32M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares1.27M
TypeSH
Market value$37.28M
1.26%
Sole
1.27M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NUVALENT INCSOLE | COM | 5M | SH | $511.50M 17.30% | 5M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 4.80M | SH | $400.85M 13.56% | 4.80M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 480.37K | SH | $260.40M 8.81% | 480.37K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 5.31M | SH | $240.99M 8.15% | 5.31M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 2.52M | SH | $128.60M 4.35% | 2.52M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 2.45M | SH | $122.65M 4.15% | 2.45M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 2.40M | SH | $109.06M 3.69% | 2.40M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 904.53K | SH | $103.36M 3.50% | 904.53K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 4.33M | SH | $84.63M 2.86% | 4.33M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 2.44M | SH | $80.27M 2.72% | 2.44M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 2.79M | SH | $74.44M 2.52% | 2.79M | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 1.50M | SH | $73.60M 2.49% | 1.50M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.90M | SH | $65.88M 2.23% | 2.90M | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 5.50M | SH | $65.71M 2.22% | 5.50M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 2.34M | SH | $57.63M 1.95% | 2.34M | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 4.09M | SH | $53.74M 1.82% | 4.09M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.61M | SH | $49.79M 1.68% | 4.61M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 1.10M | SH | $48.48M 1.64% | 1.10M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 931.48K | SH | $46.97M 1.59% | 931.48K | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 200.34K | SH | $44.98M 1.52% | 200.34K | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 3.90M | SH | $44.55M 1.51% | 3.90M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 701.82K | SH | $41.22M 1.39% | 701.82K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 1.36M | SH | $38.85M 1.31% | 1.36M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 2.32M | SH | $38.85M 1.31% | 2.32M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 1.27M | SH | $37.28M 1.26% | 1.27M | 0.00 | 0.00 |
Page 1 of 2